NCT00329368: Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer |
|
|
| Completed | 1 | 13 | US | EC90 (KLH-FITC), Keyhole limpet hemocyanin fluorescein, GPI-0100, Saponin-based adjuvant, EC17 (Folate-FITC), folate-fluorescein conjugate, folate-hapten conjugate, Interleukin-2, IL-2, Proleukin, Interferon-alpha, IFN-alpha, Intron-A | Endocyte | Cancer | 12/07 | 06/08 | | |
